An important mission of the ERN EpiCARE is to support education and training of young doctors already working in the field of rare and complex epilepsies. One of the concrete actions in that aim, recently decided by the Executive Committee following a proposal of the Education and Training Working Group, is to support up to 5 participants at major scientific congresses in the field, held in Europe and organized by:
- the ILAE: 14th European Epilepsy Congress in Geneva; July 2022) / 35th International Epilepsy Congress in Dublin ; Sept 2023
- the European Paediatric Neurology Society : Glasgow, April 2022 / Prague, June 2023
- the European Academy of Neurology : Vienna; June 2022 / Budapest July 2023
The support will not exceed 1000€ and can only cover, based on the presentation of receipts, registration fees, accommodation expenses corresponding to the dates of the congress and travel. The candidate(s) selected will be reimbursed after the congress.
Requirements for candidates:
- Must be a member of the junior healthcare staff (<3 year since completion of training and <35 years old), residents, fellows or PhD students working in one of the Full or Affiliated members of EpiCARE (Certificate from Head of Dpt requested)
- Must be the first and presenting author of an already accepted communication (oral or poster), attending the congress in person
- The topic treated must be related to rare and/or complex epilepsies and represent original work
- The candidates will be asked to attest that they did not receive full support from their institution or pharma.
- In case of partial support, candidates remain eligible, but will be requested to provide information on amount received and type of support (ex. Registration fee etc.)
Judgement criteria will be based on scientific content, respect of all the above mentioned requirements and quality of the presentation at the congress (one or more senior staff of EpiCARE will be asked to attend the session and/or the presentation of a poster). A motivation letter on future engagement in the field of rare and complex epilepsies will also be taken under consideration.
All candidacies (abstract, confirmation of acceptance to the congress and candidacty letter) should be send at least 4 weeks before the corresponding congress to Nicola Openshaw-Lawrence and Sébile Tchaicha and will be carefully evaluated by the EpiCARE Research Council
